France - Hormones, Prostaglandins, Thromboxanes and Leukotrienes - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingFrance: Market for Hormones, Prostaglandins, Thromboxanes And Leukotrienes 2024
Market Size for Hormones, Prostaglandins, Thromboxanes And Leukotrienes in France
After two years of growth, the French market for hormones, prostaglandins, thromboxanes and leukotrienes decreased by -54.3% to $X in 2021. Overall, consumption recorded a deep reduction. Over the period under review, the market hit record highs at $X in 2012; however, from 2013 to 2021, consumption stood at a somewhat lower figure.
Production of Hormones, Prostaglandins, Thromboxanes And Leukotrienes in France
In value terms, hormones, prostaglandins, thromboxanes and leukotrienes production rose to $X in 2021 estimated in export price. In general, production recorded a pronounced slump. The most prominent rate of growth was recorded in 2018 when the production volume increased by 20% against the previous year. Over the period under review, production hit record highs at $X in 2013; however, from 2014 to 2021, production stood at a somewhat lower figure.
Exports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes
Exports from France
Hormones, prostaglandins, thromboxanes and leukotrienes exports from France skyrocketed to X tons in 2021, with an increase of 43% against the year before. Over the period under review, exports, however, saw a noticeable downturn. The pace of growth appeared the most rapid in 2015 with an increase of 58% against the previous year. Over the period under review, the exports reached the peak figure at X tons in 2012; however, from 2013 to 2021, the exports stood at a somewhat lower figure.
In value terms, hormones, prostaglandins, thromboxanes and leukotrienes exports skyrocketed to $X in 2021. Overall, exports, however, showed a perceptible descent. The most prominent rate of growth was recorded in 2015 when exports increased by 67%. As a result, the exports reached the peak of $X. From 2016 to 2021, the growth of the exports remained at a somewhat lower figure.
Exports by Country
Spain (X tons) was the main destination for hormones, prostaglandins, thromboxanes and leukotrienes exports from France, accounting for a 26% share of total exports. Moreover, hormones, prostaglandins, thromboxanes and leukotrienes exports to Spain exceeded the volume sent to the second major destination, the United States (X tons), twofold. Austria (X tons) ranked third in terms of total exports with a 9.7% share.
From 2012 to 2021, the average annual rate of growth in terms of volume to Spain stood at +27.5%. Exports to the other major destinations recorded the following average annual rates of exports growth: the United States (-3.2% per year) and Austria (+8.5% per year).
In value terms, Austria ($X), the United States ($X) and Spain ($X) appeared to be the largest markets for hormones, prostaglandins, thromboxanes and leukotrienes exported from France worldwide, together comprising 49% of total exports. Germany, Sweden, Italy, Japan, Belgium, the UK, Canada, China and the Czech Republic lagged somewhat behind, together accounting for a further 35%.
Among the main countries of destination, China, with a CAGR of +62.7%, recorded the highest rates of growth with regard to the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.
Export Prices by Country
The average export price for hormones, prostaglandins, thromboxanes and leukotrienes stood at $X per kg in 2021, waning by -3.7% against the previous year. Over the period under review, the export price showed a mild shrinkage. The growth pace was the most rapid in 2014 an increase of 25% against the previous year. The export price peaked at $X per kg in 2016; however, from 2017 to 2021, the export prices stood at a somewhat lower figure.
There were significant differences in the average prices for the major export markets. In 2021, the country with the highest price was Japan ($X per kg), while the average price for exports to the Czech Republic ($X per kg) was amongst the lowest.
From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to Canada (+10.1%), while the prices for the other major destinations experienced more modest paces of growth.
Imports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes
Imports into France
In 2021, after two years of growth, there was significant decline in supplies from abroad of hormones, prostaglandins, thromboxanes and leukotrienes, when their volume decreased by -55.9% to X tons. In general, imports saw a pronounced shrinkage. The pace of growth was the most pronounced in 2017 when imports increased by 108%. As a result, imports reached the peak of X tons. From 2018 to 2021, the growth of imports remained at a somewhat lower figure.
In value terms, hormones, prostaglandins, thromboxanes and leukotrienes imports shrank rapidly to $X in 2021. Over the period under review, imports saw a noticeable decrease. The pace of growth appeared the most rapid in 2017 with an increase of 68% against the previous year. As a result, imports attained the peak of $X. From 2018 to 2021, the growth of imports remained at a somewhat lower figure.
Imports by Country
China (X tons), Austria (X tons) and Belgium (X tons) were the main suppliers of hormones, prostaglandins, thromboxanes and leukotrienes imports to France, with a combined 62% share of total imports.
From 2012 to 2021, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by Belgium (with a CAGR of +54.7%), while imports for the other leaders experienced mixed trend patterns.
In value terms, Belgium ($X) constituted the largest supplier of hormones, prostaglandins, thromboxanes and leukotrienes to France, comprising 54% of total imports. The second position in the ranking was held by the United States ($X), with a 17% share of total imports. It was followed by Austria, with a 9.8% share.
From 2012 to 2021, the average annual rate of growth in terms of value from Belgium amounted to +50.6%. The remaining supplying countries recorded the following average annual rates of imports growth: the United States (-8.5% per year) and Austria (-13.5% per year).
Import Prices by Country
In 2021, the average import price for hormones, prostaglandins, thromboxanes and leukotrienes amounted to $X per kg, increasing by 27% against the previous year. Overall, import price indicated modest growth from 2012 to 2021: its price increased at an average annual rate of +1.1% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. The most prominent rate of growth was recorded in 2018 when the average import price increased by 28%. The import price peaked at $X per kg in 2014; however, from 2015 to 2021, import prices stood at a somewhat lower figure.
There were significant differences in the average prices amongst the major supplying countries. In 2021, the country with the highest price was Belgium ($X per kg), while the price for China ($X per kg) was amongst the lowest.
From 2012 to 2021, the most notable rate of growth in terms of prices was attained by the Netherlands (+8.3%), while the prices for the other major suppliers experienced mixed trend patterns.
Source: IndexBox Platform
Frequently Asked Questions (FAQ) :
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in France. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21105200 - Hormones, prostaglandins, thromboxanes and leukotrienes, n atural or reproduced by synthesis, derivatives and structural analogues thereof, including chain modified polypeptides, u sed primarily as hormones
Country coverage:
- France
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in France
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
Recommended reports
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in Asia.
This report provides an in-depth analysis of the global market for hormones, prostaglandins, thromboxanes and leukotrienes.
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in the EU.
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in the U.S..
This report provides an in-depth analysis of the market for hormones, prostaglandins, thromboxanes and leukotrienes in China.